Fig. 2.
Patient Global Impression of Change ratings at Weeks 1, 4, and 8 for patients taking tapentadol extended release (full analysis population). None of the patients reported a rating of “very much worse” at Week 1, 4, or 8
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.